A new immunotherapy schedule in addition to first-line hormone therapy for metastatic breast cancer patients in a state of clinical benefit during hormone therapy.
| Autor: | Nicolini, Andrea1 (AUTHOR) andrea.nicolini@med.unipi.it, Rossi, Giuseppe2 (AUTHOR), Ferrari, Paola1 (AUTHOR), Morganti, Riccardo3 (AUTHOR), Carpi, Angelo4 (AUTHOR) |
|---|---|
| Zdroj: | Journal of Molecular Medicine. Mar2020, Vol. 98 Issue 3, p375-382. 8p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|
Full text from SpringerLink